Cognitive and behavioral therapies alone versus in combination with fluvoxamine in the treatment of obsessive compulsive disorder

Journal of Nervous and Mental Disease

Volumn 186, Issue 8, 1998, Pages 492-499

  Van Balkom, Anton J L M ^a,d   De Haan, Else ^b   Van Oppen, Patricia ^a   Spinhoven, Philip ^e   Hoogduin, Kees A L ^c   Van Dyck, Richard ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b Psychiatric Outpatient Department   (Netherlands)

^c RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

^d VU UNIVERSITY AMSTERDAM   (Netherlands)

^e NONE

Author keywords

[No Author keywords available]

Indexed keywords

FLUVOXAMINE;

ADULT; ANXIETY NEUROSIS; ARTICLE; BEHAVIOR THERAPY; CLINICAL TRIAL; COGNITIVE THERAPY; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OBSESSION; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SOMNOLENCE; TREATMENT OUTCOME;

ADULT; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; COGNITIVE THERAPY; COMBINED MODALITY THERAPY; DESENSITIZATION, PSYCHOLOGIC; FEMALE; FLUVOXAMINE; HUMANS; MALE; MIDDLE AGED; OBSESSIVE-COMPULSIVE DISORDER; PATIENT DROPOUTS; PERSONALITY INVENTORY; PSYCHIATRIC STATUS RATING SCALES; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 0031846241     PISSN: 00223018     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005053-199808000-00007     Document Type: Article

References (22)

1. American Psychiatric Association (1987) Diagnostic and statistical manual of mental disorders (3rd ed, rev). Washington, DC: Author.
2. Beck AT, Ward CH, Mendelson M, Mock JE, Erbaugh J (1961) An inventory for measuring depression. Arch Gen Psychiatry 4:561-571.
3. Cottraux J, Mollard E, Bouvard M, Marks I, Sluys M, Nury AM, Douge R, Ciadella P (1990) A controlled study of fluvoxamine and exposure in obsessive-compulsive disorder. Int Clin Psychopharmacol 5:17-30.
4. Derogatis LR (1977) SCL-90. Administration, scoring and procedures manual-I for the revised version and other instruments of the psychopathology rating scales. Baltimore: Clinical Psychometrics Research Unit, The John Hopkins University School of Medicine.
5. Di Nardo PA, O'Brien GT, Barlow DH, Waddell MT, Blanchard EB (1983) Reliability of DSM-III anxiety disorder categories using a new structured interview. Arch Gen Psychiatry 40: 1070-1075.
6. Elkin I, Pilkonis PA, Docherty JP, Sotsky SM (1988a) Conceptual and methodological issues in comparative studies of psychotherapy and pharmacotherapy: I. Active ingredients and mechanisms of change. Am J Psychiatry 145:909-917.
7. Elkin I, Pilkonis PA, Docherty JP, Sotsky SM (1988b) Conceptual and methodological issues in comparative studies of psychotherapy and pharmacotherapy: II. Nature and timing of treatment effects. Am J Psychiatry 145:1070-1076.
8. Emmelkamp PMG (1982) Phobic and obsessive-compulsive disorders; theory, research and practice. New York: Plenum.
9. Fawcett S (1987) Symptoms, signs, side effects checklist. Psychopharmacol Bull 23:322-323.
10. Foa EB, Kozak MJ, Steketee GS, McCarthy PR (1992) Treatment of depressive and obsessive-compulsive symptoms in OCD by imipramine and behavior therapy. Br J Clin Psychol 31:279-292.
11. Goodman WK, Price LH, Rasmussen SA, Delgado PL, Heninger GR, Charney DS (1989a) Efficacy of fluvoxamine in obsessive-compulsive disorder. Arch Gen Psychiatry 46:36-44.
12. Goodman WK, Price LH, Rasmussen SA, Mazure C, Fleischmann RL, Hill CL, Heninger GR, Chamey DS (1989b) The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability. Arch Gen Psychiatry 46:1006-1011.
13. Hollon SD, Shelton RC, Loosen PT (1991) Research considerations in evaluating combined treatment. In BD Beitman, GL Klerman (Eds), Integrating pharmacotherapy and psychotherapy (pp 353-379). Washington, DC: American Psychiatric Press.
14. Hoogduin CAL, Hoogduin WA (1984) The out-patient treatment of patients with an obsessive-compulsive disorder. Behav Res Ther 22:455-460.
15. Jenike MA, Baer L, Minichiello WE (1990) Obsessive-compulsive disorders: Theory and practice. Chicago: Year Book.
16. Marks IM (1987) Fears, phobias and rituals. New York: Oxford University Press.
17. Marks IM, Lelliott P, Basoglu M, Noshirvani H, Monteiro W, Cohen D, Kasvikis Y (1988) Clomipramine, self-exposure and therapist-aided exposure for obsessive-compulsive rituals. Br J Psychiatry 152:522-534.
18. Marks IM, Stern RS, Mawson D, Cobb J, McDonald R (1980) Clomipramine and exposure for obsessive-compulsive rituals: I. Br J Psychiatry 136:1-25.
19. van Balkom AJLM, van Oppen P, Vermeulen AWA, van Dyck R, Nauta MCE, Vorst HCM (1994) A meta-analysis on the treatment of obsessive compulsive disorder. Clin Psychol Rev 14: 359-381.
20. van Oppen P, Arntz A (1994) Cognitive therapy for obsessive compulsive disorder. Behav Res Ther 32:79-87.
21. van Oppen P, de Haan E, van Balkom AJLM, Spinhoven Ph, Hoogduin K, van Dyck R (1995a) Cognitive therapy and exposure in vivo in the treatment of obsessive compulsive disorder. Behav Res Ther 33:379-390.
22. van Oppen P, Hoekstra RJ, Emmelkamp PMG (1995b) Structure of obsessive compulsive symptoms. Behav Res Ther 33:15-23.